Nano Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 25 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -82.01%
- Profit Growth -66.65%
- Ebitda -179.20%
- Net Worth -19.95%
- Total Assets -0.49%
About Nano Biotech
Nano Biotech Private Limited (NBPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 September 1999 and has a history of 25 years and five months. Its registered office is in Punjab, Punjab.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Maninder Kaur, Balwant Singh, and Sobhveer Sandhu serve as directors at the Company.
Company Details
- Location Punjab, Punjab
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U33112PB1999PTC022894
- Company No.
022894
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Sep 1999
- Date of AGM
08 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
What products or services does Nano Biotech Private Limited offer?
Nano Biotech Private Limited offers a wide range of products and services, including Ayurvedic Herbal Syrups & Tonics, Ayurvedic Health Tonic, Health Care Service.
Who are the key members and board of directors at Nano Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Maninder Kaur  | Director | 02-Sep-1999 | Current |
| Balwant Singh | Director | 02-Sep-1999 | Current |
| Sobhveer Sandhu | Director | 14-Jan-2022 | Current |
Financial Performance of Nano Biotech.
Nano Biotech Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 82.01% decrease. The company also saw a substantial fall in profitability, with a 66.65% decrease in profit. The company's net worth observed a substantial decline by a decrease of 19.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nano Biotech?
In 2023, Nano Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nano Laboratories Pprivate LimitedManinder Kaur, Balwant Singh and 1 more are mutual person
- Acculine Diagnostics Private Limited
Maninder Kaur is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nano Biotech?
Unlock and access historical data on people associated with Nano Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nano Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nano Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
